ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201459; 2) Community: the network communities that were significantly associated with the response to NSC 201459; 3) Molecule: the relationships between components within communities and NSC 201459; 4) MDR: the compounds that were significantly associated with the NSC 201459.

NSC Compound Enrichment Correlation
NSC 742860 Null 0.0171490505199913 0.35377381
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.0171490505199913 0.26312864
NSC 743691 Null 0.0171490505199913 0.26117104
NSC 745455 Null 0.0171490505199913 0.37861899
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0171490505199913 0.095567353
NSC 757113 METHOTREXATE(+/-) 0.0171490505199913 0.2973572
NSC 760181 9-(3-fluorobenzyl)-7-(3-fluorobenzyloxy)-2-(4-fluorobenzyl)-1-methyl-9H-beta-carbolinium bromide 0.0171490505199913 0.13902429
NSC 208734 ACLACINOMYCIN A 0.0177048892222172 0.32850435
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0177048892222172 0.3647821
NSC 373355 Saframycin R 0.0177048892222172 0.3185882
Total:126  Current:60    [First] [Prev] [Next] [Last]